Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults

Completed · Phase 4 · Has a placebo group

Conditions studied: Influenza, Healthy

In brief

This prospective annual release study is designed to evaluate the safety on new influenza virus vaccine strains to be included in FluMist Quadrivalent for the 2013-2014 influenza season.

Key facts

Study ID
NCT01859143
Run by
MedImmune LLC
People needed
300
Starts
2013-05-01
Expected to finish
2013-12-01
Last updated by the study team
2014-11-10

Who can join

Age: 18 and older, up to 49. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.